Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) Long Term Debt

As of the most recent data (June 2026), ELAT shows a long-term debt of $3.8B. That compares with $4.1B in the prior-year period — down 7.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ELAT's long-term debt is now $3.8B (was $4.1B) — a 7.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is outperforming or lagging.

Tracking ELAT's long-term debt over time shows whether Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.8B That compares with $4.1B in the prior-year period — down 7.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $3.8B) with ownership activity and broader fundamentals.

Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s long-term debt is $3.8B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.